View Older Stories View More Recent Stories
-
TCR² Therapeutics Announces Pricing of Public Offering of Common Stock
-
TCR² Therapeutics Announces Pricing of Public Offering of Common Stock
-
Freddie Mac Prices $901 Million Multifamily K-Deal, K-F82
-
TZP Group Continues to Expand its Platform with Nine New Hires
-
AgroFresh Announces Successful Completion of Comprehensive Refinancing
-
TCR2 Therapeutics (TCRR) to Offer 6M Common Shares
-
TCR² Therapeutics Announces Proposed Public Offering of Common Stock
-
TCR² Therapeutics Announces Proposed Public Offering of Common Stock
-
Freeport-McMoRan Completes Sale of $1.5 Billion of Senior Notes
-
TCR2 Therapeutics (TCRR) PT Raised to $45 at BMO Capital
-
BMO Capital Reiterates Market Perform Rating on Hasbro (HAS) Ahead of 2Q Report
-
BMO Capital Reiterates Market Perform Rating on Facebook (FB) Ahead of 2Q
-
Rackspace Technology Announces Launch of Initial Public Offering
-
Recommended All-Cash Takeover Offer of Cardinal Resources by Shandong Gold
-
American Express (AXP) PT Raised to $100 at BMO Capital Following 2Q
-
BMO Capital Starts Dun & Bradstreet (DNB) at Outperform
-
Fed meeting expected to leave U.S. bond-stock relationship out of whack
-
Sustainable Innovation & Health Dividend Fund Files Final Prospectus
-
Freeport-McMoRan (FCX) PT Raised to $17 at BMO Capital, Following Earnings
-
Freddie Mac Prices $330 Million Multifamily K-Deal, K-J30
-
Rupert Resources Closes Equity Financings Totalling C$25.6 Million
-
These Penny Stocks Just Hit New 52-Week Highs; Now What?
-
Revised and Improved Takeover Proposal Received From Shandong Gold
-
BMO Capital Starts PolyPid Ltd. (PYPD) at Outperform
-
ELS Reports Second Quarter Results
-
BMO Capital Downgrades Noble Energy (NBL) to Market Perform
-
Revival Gold Announces C$10 Million Bought Deal Financing
-
BioXcel Therapeutics (BTAI) PT Raised to $104 at BMO Capital; 'BXCL501 Clean SERENITY Data Supports Approval'
-
Pre-Open Movers 07/20: (SRNE) (BNTX) (NBL) Higher; (NKLA) (MRNA) Lower (more...)
-
BMO Capital Starts Immunic Inc. (IMUX) at Outperform, PT $40
-
Ally Financial (ALLY) PT Raised to $34 at BMO Capital, Following Earnings
-
Pandion Therapeutics (PAND) IPO Opens 50% Higher
-
Pandion Therapeutics, Inc. (PAND) Prices 7.5M Share IPO at $18/Sh
-
Pandion Therapeutics Announces Pricing of Initial Public Offering
-
Pandion Therapeutics Announces Pricing of Initial Public Offering
-
Foreigners sell Treasuries in May, buy record amount of U.S. stocks: data
-
Postal Realty Trust (PSTL) Prices 3.5M Share Follow-On Offering at $13/Sh
-
UPDATE: BMO Capital Starts Altra Holdings (AIMC) at Outperform
-
UPDATE: BMO Capital Upgrades Cognizant Technology Solutions (CTSH) to Outperform
-
Postal Realty Trust Announces Pricing of Follow-On Offering
-
Bank of Canada sees economy below pre-COVID levels until 2022, with rates remaining low
-
Take No Action - On-Market Takeover Bid by Nord Gold SE
-
Atalaya Mining PLC Announces Q2 2020 Operations Update
-
Investigator-Led Tavalisse Study in COVID-19 Positive for Rigel Pharmaceuticals (RIGL) - BMO
-
Gold Terra Resource Corp. Announces Closing of C$7.13 Million Financing
-
MediPharm Labs Appoints BMO Capital Markets Executive to Board of Directors
-
MediPharm Labs Appoints BMO Capital Markets Executive to Board of Directors
-
BMO Capital Upgrades Harley-Davidson (HOG) to Outperform
-
Freeport-McMoRan Announces Upsizing and Pricing of $1.5 Billion of Senior Notes
-
Postal Realty Trust (PSTL) Announces Proposed 3.5M Class A Share Offering

